Inositol lipid binding and membrane localization of isolated pleckstrin homology (PH) domains. Studies on the PH domains of phospholipase C delta 1 and p130.

Endocrinology and Reproduction Research Branch, NICHD/National Institutes of Health, 49 Convent Drive, Bldg. 49, Bethesda, MD 20892, USA.
Journal of Biological Chemistry (Impact Factor: 4.6). 08/2002; 277(30):27412-22.
Source: PubMed

ABSTRACT The relationship between the ability of isolated pleckstrin homology (PH) domains to bind inositol lipids or soluble inositol phosphates in vitro and to localize to cellular membranes in live cells was examined by comparing the PH domains of phospholipase Cdelta(1) (PLCdelta(1)) and the recently cloned PLC-like protein p130 fused to the green fluorescent protein (GFP). The prominent membrane localization of PLCdelta(1)PH-GFP was paralleled with high affinity binding to inositol 1,4,5-trisphosphate (InsP(3)) as well as to phosphatidylinositol 4,5-bisphosphate-containing lipid vesicles or nitrocellulose membrane strips. In contrast, no membrane localization was observed with p130PH-GFP despite its InsP(3) and phosphatidylinositol 4,5-bisphosphate-binding properties being comparable with those of PLCdelta(1)PH-GFP. The N-terminal ligand binding domain of the type I InsP(3) receptor also failed to localize to the plasma membrane despite its 5-fold higher affinity to InsP(3) than the PH domains. By using a chimeric approach and cassette mutagenesis, the C-terminal alpha-helix and the short loop between the beta6-beta7 sheets of the PLCdelta(1)PH domain, in addition to its InsP(3)-binding region, were identified as critical components for membrane localization in intact cells. These data indicate that binding to the inositol phosphate head group is necessary but may not be sufficient for membrane localization of the PLCdelta(1)PH-GFP fusion protein, and motifs located within the C-terminal half of the PH domain provide auxiliary contacts with additional membrane components.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Phosphatidylinositolphosphates (PIPs) are phospholipids that contain a phosphorylated inositol head group. PIPs represent a minor fraction of the total phospholipids, yet they are involved in many regulatory processes such as cell signalling and intracellular trafficking. Membrane compartments are enriched or depleted in specific PIPs, which constitute a signature for these compartments and contribute to their identity. The precise subcellular localisation and dynamics of most PIP species is not fully understood in plants. Here, we designed genetically encoded biosensors with distinct relative affinities and expressed them stably in Arabidopsis thaliana. Analysis of this multi-affinity "PIPline" marker set revealed previously unrecognized localisation for various PIPs in root epidermis. Notably, we found that PI(4,5)P2 is able to drive PIP2 -interacting protein domains to the plasma membrane in non-stressed root epidermal cells. Our analysis further revealed that there is a gradient of PI4P, with the highest concentration at the plasma membrane, intermediate concentration in post-Golgi/endosomal compartments and lowest concentration in the Golgi. Finally, we also uncovered that there is a similar gradient of PI3P from high in late endosomes to low in the tonoplast. All together our library extends the palette of available PIP biosensors and should promote rapid progress in our understanding of PIP dynamics in plants. This article is protected by copyright. All rights reserved.
    The Plant Journal 10/2013; · 6.82 Impact Factor
  • Source
    Article: Volume 4(
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction Head and neck cancer is the eighth leading cause of cancer death worldwide [1]. In patients diagnosed with head and neck cancer, Squamous Cell Carcinoma (SCC) is the most frequent tumor type, characterized by local tumor aggressiveness, and high frequency of second primary tumors [2]. Although, radiotherapy plays a pivotal role in head and neck SCC treatment, recurrent tumors frequently show increased radioresistance [3]. It is known for instance, that exposure of SCC to X-rays therapy triggers compensatory pathways that can induce cell survival and repopulation following radiation [4]. Therefore, for SCC, resistance to radiotherapy is one of the major barriers in the treatment [5], and little is known about the molecular and cellular mechanisms that leads to radioresistance. Moreover, the combined effects of radiation field uniformity and dose fractionation schedules on SCC have not been studied in detail [6]. One molecular target demonstrated to be important for the SCC treatment has been the Epidermal Growth Factor (EGF) [7]. EGF receptor (EGFR) exhibits tyrosine-kinase activity and through activation of its downstream signals regulates cell proliferation, differentiation and survival [8]. It has been demonstrated that EGFR is frequently over expressed in malignant tumors, and its over expression correlates with increased cellular resistance to consecutive radiation exposure [4,8]. Radiation activates EGFR, which in turn stimulates phospholipase C (PLC) activity, inositol-1,4,5-trisphosphate (IP 3) production and release of Ca 2+ from internal stores [9]. Intracellular Ca 2+ participates as a second messenger in several signaling pathways, coordinating key events in a variety of cellular functions [10]. Particularly, nuclear Ca 2+ signaling is known to play an important role on tumor growth [11,12]. For instance, we had previously demonstrated that nuclear Ca 2+ regulates the expression of genes involved in cell proliferation, and also showed that the buffering of nuclear Ca 2+ impairs the growth of cancer cells in vitro as well as in vivo [11,12]. Nevertheless, there is no report regarding the cellular effect of nuclear Ca 2+ buffering associated to X-rays on cell proliferation. In the present work, we investigated whether nuclear Ca 2+ buffering could improve the effect of clinical doses of X-rays on human SCC growth. For that, we developed a refined in vitro daily fractioned irradiation model, based on head and neck radiotherapy protocol, to evaluate the role of the association therapy on cell proliferation. We found that nuclear Ca 2+ buffering increased radiation efficacy, at least Abstract Background: Calcium (Ca 2+) signaling within the nucleus is known to play a crucial role in cell proliferation. The aim of this study was to investigate whether nuclear Ca 2+ buffering could improve the antitumor effect of X-rays therapy on Human Squamous Cell Carcinoma (HSCC).
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: All subtypes of KCNQ channel subunits (KCNQ1-5) require calmodulin as a co-factor for functional channels. It has been demonstrated that calmodulin plays a critical role in KCNQ channel trafficking as well as calcium-mediated current modulation. However, how calcium-bound calmodulin suppresses the M-current is not well understood. In this study, we investigated the molecular mechanism of KCNQ2 current suppression mediated by calcium-bound calmodulin. We show that calcium induced slow calmodulin dissociation from the KCNQ2 channel subunit. In contrast, in homomeric KCNQ3 channels, calcium facilitated calmodulin binding. We demonstrate that this difference in calmodulin binding was due to the unique cysteine residue in the KCNQ2 subunit at aa 527 in Helix B, which corresponds to an arginine residue in other KCNQ subunits including KCNQ3. In addition, a KCNQ2 channel associated protein AKAP79/150 (79 for human, 150 for rodent orthologs) also preferentially bound calcium-bound calmodulin. Therefore, the KCNQ2 channel complex was able to retain calcium-bound calmodulin either through the AKPA79/150 or KCNQ3 subunit. Functionally, increasing intracellular calcium by ionomycin suppressed currents generated by KCNQ2, KCNQ2(C527R) or heteromeric KCNQ2/KCNQ3 channels to an equivalent extent. This suggests that a change in the binding configuration, rather than dissociation of calmodulin, is responsible for KCNQ current suppression. Furthermore, we demonstrate that KCNQ current suppression was accompanied by reduced KCNQ affinity toward phosphatidylinositol 4,5-bisphosphate (PIP2) when assessed by a voltage-sensitive phosphatase, Ci-VSP. These results suggest that a rise in intracellular calcium induces a change in the configuration of CaM-KCNQ binding, which leads to the reduction of KCNQ affinity for PIP2 and subsequent current suppression.
    PLoS ONE 12/2013; 8(12):e82290. · 3.53 Impact Factor


Available from
May 28, 2014